Back

Thrombus attenuation predicts natural history of hypo-attenuating leaflet thickening after transcatheter aortic valve replacement

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiac computed tomography in valvular heart disease Valvular Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kajetan Grodecki

Medical University of Warsaw, Warsaw (Poland)

8 More presentations in this session

Presentation thumbnail
Diagnostic performance of computed tomography-derived fractional flow reserve in patients with severe aortic stenosis
Doctor S. Kido (Matsuyama, JP)
Abstract Slides Video
Presentation thumbnail
Calculation of intraprocedural hemodynamics with computational functional dynamic in mitral valve edge-to-edge repair
Doctor J. Kirchner (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
Lead-related tricuspid regurgitation: an important phenotype seen through the lens of computed tomography
Doctor D. Margonato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Epicardial adipose tissue volumes for long-term risk stratification in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
Mr A. Schulz (Boston, US)
Abstract Slides Video
Presentation thumbnail
Significant impact of a novel whole heart motion correction algorithm on cardiac computed tomography and aortic valve calcium scores
Doctor S. Aoki (Chiba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac computed tomography in valvular heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Computed tomography-derived Hounsfield units for the differentiation between thrombosis and leaflet fibrosis/calcification in bioprosthetic heart valves
thumbnail
Congress Presentation
Hypercoagulability and inflammation indicate increased risk for hypoattenuated leaflet thickening in patients with transcatheter aortic valve replacement
thumbnail
Congress Presentation
Management of bioprosthetic valve thrombosis following transcatheter tricuspid valve replacement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources